APCCC 2024: Bridging Clinical Gaps in Prostate Cancer Care - Silke Gillessen
Silke Gillessen
Silke Gillessen discusses upcoming APCCC 2024 and delves into how the conference will tackle crucial topics from GU ASCO 2024, highlighting the dynamic field of prostate cancer treatment.
Triple-Drug Therapies Usher in Sea Change for Men With High-Risk Prostate Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen
Zachary Klaassen
Rashid Sayyid and Zach Klaassen discuss the amended AUA guidelines for advanced prostate cancer, focusing on triplet therapy for metastatic hormone-sensitive prostate cancer (mHSPC) and non-metastatic castrate-resistant prostate cancer (M0 CRPC).